Article Details
Retrieved on: 2022-09-11 02:28:46
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Wedbush raised their price target on shares of Day One Biopharmaceuticals from $32.00 to $35.00 and gave the stock an “outperform” rating in a ...
Article found on: www.etfdailynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here